Get the Stockscreener App
0.5417
0.04%
0.0017
Matinas Biopharma Holdings Inc Stock (MTNB) Forecast
The Matinas Biopharma Holdings Inc (MTNB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.6444, representing a +18.95% increase from the current price of $0.5417. The highest analyst price target is $1.1578, and the lowest is $0.131.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MTNB Price Target
Average 0.8834
(+63.09% Upside)
Is Matinas Biopharma Holdings Inc (MTNB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.78 | Buy |
| STOCH(9,6) | 15.26 | Buy |
| STOCHRSI(14) | 69.65 | Neutral |
| MACD(12,26) | -0.5809 | Buy |
| ADX(14) | 38.50 | Sell |
| William %R | -89.57 | Buy |
| CCI(14) | -57.50 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6583
Sell
|
0.7065
Sell
|
| MA20 |
1.0578
Sell
|
1.1407
Sell
|
| MA50 |
2.5227
Sell
|
1.7568
Sell
|
| MA100 |
1.6165
Sell
|
1.6332
Sell
|
| MA200 |
0.9125
Sell
|
1.2024
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MTNB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MTNB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.78 indicates that MTNB is oversold. This indicates that MTNB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 15.26 indicates that MTNB is oversold. This indicates that MTNB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.65 indicates that MTNB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.5 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.5 indicates that MTNB is still oversold but not to an extreme extent.
Long-term MTNB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Matinas Biopharma Holdings Inc financial reports and earnings history, Matinas Biopharma Holdings Inc (MTNB) stock could reach $0.7074 by 2030, $0.4119 by 2040 and $1.603 by 2050. See the projected annual prices until 2050 of the Matinas Biopharma Holdings Inc stock below:
- Matinas Biopharma Holdings Inc (MTNB) is expected to reach an average price of $0.2157 in 2035, with a high prediction of $0.2169 and a low estimate of $0.2183. This indicates an $-60.18% rise from the last recorded price of $0.5417.
- Matinas Biopharma Holdings Inc (MTNB) stock is projected to chart a bullish course in 2040, with an average price target of $0.2993, representing an $-44.74% surge from its current level. The forecast ranges from a conservative $0.3103 to a sky-high $0.4119.
- Our analysts predict Matinas Biopharma Holdings Inc (MTNB) to jump 46.53% by 2045, soaring from $0.8176 to an average price of $0.7937, potentially reaching $0.773. While $0.8176 is the low estimate, the potential upside is significant.
- Matinas Biopharma Holdings Inc (MTNB) stock is expected to climb by 2050, reaching an average of $1.5003, a $176.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.603 and $1.6529, respectively, highlighting the market's uncertainty.
Matinas Biopharma Holdings Inc Stock (MTNB) Year by Year Forecast
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2024
Our forecast for MTNB stock price in 2024 now indicates an average price target of $0.5895 with a high forecast of $1.1578 and a low forecast of $0.0213. The average prediction reflects an increase of +8.83% from the last recorded price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $1.1227 | $0.131 | $1.1578 | +107.25% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2025
Matinas Biopharma Holdings Inc Stock (MTNB) is expected to reach an average price of $0.8834 in 2025, with a high prediction of $1.7591 and a low estimate of $0.00776. This indicates an +63.09% rise from the last recorded price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.4891 | $0.75 | $1.7591 | +174.90% |
| February, 2025 | $0.6082 | $0.5337 | $1.4514 | +12.28% |
| March, 2025 | $0.2854 | $0.2573 | $0.7305 | -47.31% |
| April, 2025 | $0.1038 | $0.0581 | $0.4996 | -80.83% |
| May, 2025 | $0.0527 | $0.00776 | $0.1855 | -90.28% |
| June, 2025 | $0.0699 | $0.0118 | $0.1268 | -87.09% |
| July, 2025 | $0.1486 | $0.0991 | $0.3091 | -72.57% |
| August, 2025 | $0.0473 | $0.0173 | $0.2216 | -91.27% |
| September, 2025 | $0.2354 | $0.0196 | $0.4118 | -56.55% |
| October, 2025 | $0.0896 | $0.0387 | $0.3367 | -83.45% |
| November, 2025 | $0.1353 | $0.021 | $0.1973 | -75.02% |
| December, 2025 | $0.1882 | $0.1191 | $0.3006 | -65.26% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2026
The predicted value for Matinas Biopharma Holdings Inc (MTNB) in 2026 is set at an average of $0.8691. Estimates vary from a peak of $1.6232 to a trough of $0.115, indicating an +60.44% surge from the present price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4373 | $0.115 | $0.4573 | -19.28% |
| February, 2026 | $0.4264 | $0.3419 | $0.6441 | -21.29% |
| March, 2026 | $1.0304 | $0.2529 | $1.6232 | +90.23% |
| April, 2026 | $0.8179 | $0.2724 | $1.14 | +50.99% |
| May, 2026 | $0.5559 | $0.4214 | $0.8491 | +2.62% |
| June, 2026 | $0.445 | $0.435 | $0.6082 | -17.85% |
| July, 2026 | $0.2113 | $0.167 | $0.4473 | -60.98% |
| August, 2026 | $0.3292 | $0.2026 | $0.3356 | -39.22% |
| September, 2026 | $0.2338 | $0.1969 | $0.4026 | -56.84% |
| October, 2026 | $0.2494 | $0.1411 | $0.2584 | -53.96% |
| November, 2026 | $0.286 | $0.1504 | $0.335 | -47.21% |
| December, 2026 | $0.7863 | $0.2596 | $1.1063 | +45.16% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Matinas Biopharma Holdings Inc (MTNB) is $0.4193, with a high forecast of $0.7886 and a low forecast of $0.0499. This indicates an -22.60% decrease from the last price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6254 | $0.5309 | $0.7886 | +15.45% |
| February, 2027 | $0.5645 | $0.4422 | $0.7745 | +4.21% |
| March, 2027 | $0.5559 | $0.389 | $0.6836 | +2.61% |
| April, 2027 | $0.41 | $0.385 | $0.6081 | -24.32% |
| May, 2027 | $0.254 | $0.1596 | $0.4537 | -53.10% |
| June, 2027 | $0.1379 | $0.0839 | $0.2943 | -74.54% |
| July, 2027 | $0.3689 | $0.0499 | $0.4722 | -31.90% |
| August, 2027 | $0.4336 | $0.327 | $0.5713 | -19.96% |
| September, 2027 | $0.3349 | $0.182 | $0.4358 | -38.17% |
| October, 2027 | $0.3321 | $0.2295 | $0.4738 | -38.69% |
| November, 2027 | $0.4479 | $0.3263 | $0.5031 | -17.31% |
| December, 2027 | $0.4568 | $0.3645 | $0.5499 | -15.68% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2028
In 2028, Matinas Biopharma Holdings Inc (MTNB) is projected to reach an average price of $0.3035, with a high projection of $0.5317 and a low estimate of $0.0753. This indicates an -43.97% fall from the last price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3666 | $0.3213 | $0.4567 | -32.33% |
| February, 2028 | $0.2686 | $0.2351 | $0.4081 | -50.41% |
| March, 2028 | $0.424 | $0.2649 | $0.5317 | -21.73% |
| April, 2028 | $0.3431 | $0.3005 | $0.4635 | -36.66% |
| May, 2028 | $0.1835 | $0.0978 | $0.3654 | -66.13% |
| June, 2028 | $0.2555 | $0.1207 | $0.2735 | -52.83% |
| July, 2028 | $0.1994 | $0.1836 | $0.2958 | -63.19% |
| August, 2028 | $0.1509 | $0.1455 | $0.2072 | -72.15% |
| September, 2028 | $0.1752 | $0.0853 | $0.2008 | -67.66% |
| October, 2028 | $0.3199 | $0.1153 | $0.4576 | -40.95% |
| November, 2028 | $0.122 | $0.1002 | $0.4044 | -77.47% |
| December, 2028 | $0.0926 | $0.0753 | $0.1503 | -82.90% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2029
The 2029 price forecast for Matinas Biopharma Holdings Inc Stock (MTNB) is $0.3306 on average, with a high prediction of $0.6612 and a low estimate of $0.000051. This represents an -38.96% decrease from the previous price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.094 | $0.0646 | $0.1617 | -82.65% |
| February, 2029 | $0.0485 | $0.0754 | $0.1252 | -91.04% |
| March, 2029 | $0.1078 | $0.071 | $0.0727 | -80.11% |
| April, 2029 | $0.0176 | $0.1038 | $0.6612 | -96.76% |
| May, 2029 | $0.00421 | $0.0165 | $0.1026 | -99.22% |
| June, 2029 | $0.00168 | $0.00432 | $0.0291 | -99.69% |
| July, 2029 | $0.017 | $0.000051 | $0.0598 | -96.87% |
| August, 2029 | $0.0121 | $0.00203 | $0.041 | -97.76% |
| September, 2029 | $0.0606 | $0.0144 | $0.0881 | -88.81% |
| October, 2029 | $0.1106 | $0.0529 | $0.2626 | -79.59% |
| November, 2029 | $0.0294 | $0.022 | $0.2069 | -94.58% |
| December, 2029 | $0.6346 | $0.0187 | $0.5244 | +17.15% |
Matinas Biopharma Holdings Inc Stock (MTNB) Price Forecast for 2030
Matinas Biopharma Holdings Inc Stock (MTNB) is expected to reach an average price of $0.5151 in 2030, with a high forecast of $1.0283 and a low forecast of $0.0019. This signifies an -4.91% decrease from the last price of $0.5417.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7919 | $0.6753 | $0.7074 | +46.18% |
| February, 2030 | $0.7214 | $0.7529 | $0.7282 | +33.17% |
| March, 2030 | $0.8153 | $0.852 | $0.78 | +50.51% |
| April, 2030 | $0.856 | $0.8708 | $0.8327 | +58.01% |
| May, 2030 | $0.9016 | $0.8897 | $0.8844 | +66.45% |
| June, 2030 | $0.6713 | $0.819 | $0.832 | +23.92% |
| July, 2030 | $0.3135 | $0.3935 | $0.5672 | -42.12% |
| August, 2030 | $0.2346 | $0.0101 | $0.6954 | -56.69% |
| September, 2030 | $0.00781 | $0.00281 | $1.0283 | -98.56% |
| October, 2030 | $0.1445 | $0.0019 | $0.2219 | -73.33% |
| November, 2030 | $0.7161 | $0.2499 | $0.4063 | +32.19% |
| December, 2030 | $0.8671 | $0.8318 | $0.7981 | +60.07% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):